Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
XChange TEC.INC RECEIVES NASDAQ MINIMUM BID PRICE DEFICIENCY NOTICE 2024-11-13 07:00
Insilico Medicine Announces Positive Topline Results of ISM001-055 for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) Developed Using Generative AI 2024-11-12 22:00
Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing 2024-11-12 21:15
2024 Tsingke High-Impact Literature Compilation - Gene Synthesis 2024-11-12 18:09
Tsingke Successfully Showcases Innovations at BIO-Europe 2024 2024-11-12 17:07
WuXi AppTec Ranked #1 in Global Life Sciences Tools & Services Industry in 2024 S&P Global Corporate Sustainability Assessment 2024-11-12 08:00
HoneyNaps AI Diagnostic Medical Software as Featured in International Journal "Digital Health" 2024-11-11 22:00
Lakeside Holding Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical (Hubei) Co., Ltd. 2024-11-11 21:45
DermRays Revolutionizing At-Home Laser Hair Removal with Innovative New Products 2024-11-11 21:00
Neurizon Therapeutics Receives Positive Opinion on Orphan Medicinal Product Designation for NUZ-001 in Europe 2024-11-11 20:30
Professor Narayanan Parameswaran's team at Michigan State University announced that Red Ginseng is effective for intestinal health and preventing bone loss 2024-11-11 13:17
Alteogen enters into an Exclusive License Agreement to Develop and Commercialize Subcutaneous ENHERTU® Enabled by Alteogen's Hybrozyme™ Technology 2024-11-11 08:07
Welcome to 2024 Chinese Congress of Holistic Integrative Oncology (2024 CCHIO)& 4th International Congress of the Asian Oncology Society (AOS2024) 2024-11-09 14:45
Lunit Shows Promise of AI in Predicting Immunotherapy Response for Rare Cancer Patients at SITC 2024 2024-11-08 22:00
Mabwell Reveals Encouraging Pre-clinical Data of 7MW4811 at the 15th World ADC Conference 2024-11-08 22:00
Samsung Biologics earns ISO certifications in recognition of business excellence 2024-11-08 20:00
Dizal Submits New Drug Application to the U.S. FDA for Sunvozertinib in Treating Relapsed or Refractory Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations 2024-11-08 18:01
Harbour BioMed Announces Submission of IND Application for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease 2024-11-08 17:45
Infinitopes to Showcase Breakthroughs on Cancer Vaccine Development at SITC 2024: Insight into a double-blind, Phase I/IIa clinical trial 2024-11-08 16:30
WuXi XDC Named Best CDMO Winner at 2024 World ADC Awards 2024-11-08 11:27
1 2 3 4 5 812